The stratified analysis results showed that the HCC patients in the high-protection group had a favorable prognosis in all the subgroups (P < 0.05) except age > 47, female, drinking, AFP ≤ 400ng/ml, and patients with cancer embolus. The gene discussed is AFP; the disease is hepatocellular carcinoma.